Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
It belongs to a class of medicines known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists
In laboratory settings, it is commonly studied in peptide signalling and copper-binding research applications
Some healthcare providers may choose to implement a stepwise dose reduction (for example, decreasing from 15 mg to 10 mg to 5 mg over several weeks) not because tapering is pharmacologically required, but to allow time for: Transitioning to alternative therapies Implementing lifestyle modifications Monitoring metabolic parameters Adjusting other medications Psychological preparation for treatment changes This approach represents clinical judgment rather than medical necessity
Medication costs fluctuate: The price might change based on the dose you get from the medication
NF-kappaB regulation in the immune system
US$ 29.85
US$ 25.62
US$ 21.79
US$ 28.86
US$ 24.09
US$ 23.63
US$ 27.81
US$ 25.42
